Navigation Links
Laser Deemed Best Treatment for Diabetic Retinopathy
Date:12/31/2009

Standard therapy still recommended over steroid injections, researchers say

THURSDAY, Dec. 31 (HealthDay News) -- Steroid injections into the eye slowed diabetes-related eye disease, though lasers remain the treatment of choice because of side effects related to the steroids, new research shows.

Researchers from the Johns Hopkins Wilmer Eye Institute gave 693 men and women who had diabetic retinopathy with macular edema either injections of a corticosteroid into their eyes as often as every four months or a laser photocoagulation, the standard treatment. The average age of the participants was 63.

Retinopathy is a long-term complication of diabetes that can lead to blindness. Macular edema, which can further interfere with vision, is a swelling of the central portion of the retina caused by fluid leakage.

Over time, retinopathy can advance to proliferative diabetic retinopathy, in which abnormal blood vessels grow on the optic nerve in the back of the eye, which communicates information from the retina to the brain, or elsewhere on the light-sensitive retina. The study authors found that steroid treatments reduced the risk of progression of diabetic retinopathy.

However, steroids did not prevent the progression of macular edema, according to the study.

And while steroids did help to improve the vision of participants, the results were no better than the laser treatments. Because the use of steroids in the eye can increase the risk of other eye diseases, including glaucoma and cataracts, lasers remain the treatment of choice for now, said lead study author Neil Bressler, a professor of ophthalmology and chief of the retina division of the eye institute.

"Steroid treatment worked, but because of safety issues, cannot be recommended routinely at this time," Bressler said in a news release from the institute. "It is a condition that can be treated safely and effectively with lasers."

The study findings are published in the December issue of Archives of Ophthalmology.

About 700,000 Americans have proliferative diabetic retinopathy, and 63,000 new cases develop each year, according to background information provided in the news release.

Corticosteroids may slow the progression of retinopathy by reducing the production of compounds that promote the growth of harmful new blood vessels, the researchers said.

More research is needed to determine if steroids can be used without increasing the risk of glaucoma or cataracts, the authors said.

More information

The U.S. National Eye Institute has more on diabetic retinopathy.



-- Jennifer Thomas



SOURCE: Johns Hopkins Wilmer Eye Institute, news release, Dec. 22, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Laser Spine Institute (LSI) Supports Jingle Bell Run
2. Entest BioMedical Enters into LOI with Advanced Light Devices to Develop Laser Platform for Stem Cell / Laser COPD Treatment
3. Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment
4. Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States
5. Laser therapy can aggravate skin cancer
6. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
7. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
8. Laser Therapy Seems to Relieve Neck Pain
9. Plastic Surgeons to Discuss Cleavage Rejuvenation, Do-It-Yourself Lasers and Other Hot Topics with the Media
10. First Temperature Monitoring Device for Laser Liposuction in St. Louis
11. Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 2017 , ... With ProGlass Prism users now have the ability to simulate ... over position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, ... ProGlass Prism users are given the tools and effects to generate a fractal ...
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... which specializes in thought leadership , media relations, social media, content marketing ... that will be powered through Act-On, an intuitive marketing automation platform. , Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma ... innovative lymphoma research and serving the lymphoma community through a comprehensive series of ... Gorce Country Club in Miami Beach to host its Swirl: Miami Wine Tasting ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... Feb. 23, 2017 Non-alcoholic steatohepataitis ... the various drugs being developed for the ... the drugs that are in various phases ... pipeline focuses on novel pharmacologic drugs & ... cell therapies, recombinant proteins and RNA-based therapeutics, ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an ... that it has acquired exclusive worldwide rights to ... innovative HDAC inhibitor targeting hematological and solid tumors. ... Phase 1 and 2 clinical trials of Abexinostat ... have already been completed, demonstrating that Abexinostat ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
Breaking Medicine Technology: